Quick Answer
LeonaBio, Inc. reported Stockholders Equity of $27.79 million for the year ending 2025.
- LeonaBio, Inc. showed a decrease of -38.0% in Stockholders Equity from 2024 to 2025.
- This data is from LeonaBio, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2019: -$17.42 million | Q3 2019: -$18.87 million | Q1 2020: -$21.29 million | Q2 2020: -$12.53 million | Q3 2020: $259.47 million | Q1 2021: $363.22 million | Q2 2021: $350.71 million | Q3 2021: $336.24 million | Q1 2022: $301.98 million | Q2 2022: $280.57 million | Q3 2022: $262.25 million | Q1 2023: $211.13 million | Q2 2023: $184.98 million | Q3 2023: $154.76 million | Q1 2024: $106.74 million | Q2 2024: $83.34 million | Q3 2024: $57.58 million | Q1 2025: $37.33 million | Q2 2025: $31.99 million | Q3 2025: $26.79 million.
- Over the full 8 years of available data (2018 to 2025), LeonaBio, Inc.'s Stockholders Equity has grown by 286.7%.
- Historical annual values: Fiscal year 2025: $27.79 million | Fiscal year 2024: $44.84 million | Fiscal year 2023: $130.19 million | Fiscal year 2022: $235.14 million | Fiscal year 2021: $321.08 million | Fiscal year 2020: $274.28 million | Fiscal year 2019: -$19.72 million | Fiscal year 2018: -$14.89 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: